🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How would you rank novel therapies such as etrasimod, risankizumab, mirikizumab, and guselkumab in UC ❓ What treatment 🎯 you are interested in ❓ Our recent NMA at CGH cghjournal.org/article/S1542-… Talat Bessissow Vipul Jairath MBChB DPhil Beatriz Gros #MondayNightIBD Shrinivas Bishu

Time to stop lumping together all patients with prior biologic 'exposure'? Our latest work in #JCC Oxford Academic found outcomes of IBD patients with prior biologic intolerance to be better than those with prior failure. academic.oup.com/ecco-jcc/advan…

Improved treatment outcomes were observed in #IBD patients compared to failure in clinical trials, suggesting that future trials should more rigorously differentiate prior failure from intolerance. Samnani et al. Vipul Jairath MBChB DPhil Parambir Dulai Neeraj Narula academic.oup.com/ecco-jcc/advan…

Congratulations to the 2024 Physician of the Year, Dr. John Marshall! 🩺! He receives this award in recognition of the impact he’s made for his patients and the quality of IBD care in Canada. #IBDMinds2024

Congratulations to Dr. Remo Panaccione, the 2024 Research Leadership award recipient! We’re honoured to recognize him for his accomplishments toward moving forward the search for cures! #IBDMinds2024

This post-hoc analysis from EXTEND found endoscopic healing as defined by MM-SES-CD < 22.5 performs better to differentiate drug vs. placebo effects compared to SES-CD based definitions of endoscopic remission. Our latest work in #JCC Oxford Academic academic.oup.com/ecco-jcc/advan…

Expect a great update and discussion from Uegw 2024 from these titans of IBD in Canada!

Diet can play a key role in the management of #IBD and is gaining acceptance slowly but surely Dietary options for IBD have in common: ✅ ⬆ whole foods ✅ ⬇ highly or ultraprocessed foods AJG - The American Journal of Gastroenterology 👇👇👇

📢 New article on this #JCAGJeudi 📰 Acceptability, feasibility, and impact of the MyGut digital health platform in the monitoring and management of inflammatory bowel disease ✍️by Jamie Zhen, Maude Simoneau, Pooja Sharma, Pascale Germain and others 🔗academic.oup.com/jcag/article/7…

The TRIUMPH study is now published in Crohns Colitis 360 IBDJournal & CC360. Thank you to The Canadian IBD Research Consortium (CIRC) for their endorsement, the investigators, and the patients for their participation. Another step to understand use of JAK inhibitors in acute severe UC! academic.oup.com/crohnscolitis3…

Congrats to Verdu Lab for receiving King Charles III Coronation Medal for her outstanding contributions to GI and celiac research! McMaster Health Sciences #cddwclm2025

Please join us for our post ECCO 2025 IBD Update to review the top presented abstracts. Expert commentary by Vipul Jairath MBChB DPhil Join Here! us02web.zoom.us/webinar/regist…

Just part of the McMaster IBD team on another busy day of clinic! Neeraj Narula McMaster University Department of Medicine Cdn Digestive Health Crohn's and Colitis Canada

Preliminary Results From a Multicenter Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's Disease Kao, et al. 📕bit.ly/4ebNtnY Millie Long Jasmohan Bajaj Paul Moayyedi Remo Panaccione, MD, FRCPC Neeraj Narula Karen Madsen

Our latest work in IBDJournal & CC360: Validation of the MM-SES-CD to predict endoscopic healing at one year. We also found it to be predictive of clinical and calprotectin remission! academic.oup.com/ibdjournal/adv…